Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ApiHealth NZ is a New Zealand-based biotechnology company that specializes in the research, development, and manufacture of high-value bee-derived health products. Established in 1998, the company is a pioneer in apitherapy, utilizing bioactive components such as bee venom, Manuka honey, propolis, and royal jelly to create therapeutic formulations. Their core product range targets joint health, immune system support, and dermatological conditions, leveraging the anti-inflammatory and antimicrobial properties of bee peptides. ApiHealth NZ maintains its own manufacturing facilities in Auckland, adhering to strict quality standards to produce both finished consumer goods and raw ingredients for the global market. The company is recognized for its innovative approach to bee venom collection and its commitment to natural, science-backed wellness solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ApiHealth NZ.